Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours

GOBO: Gene Expression-Based Outcome for Breast Cancer Online

(2011) Markus Ringnér et al.   PLoS One

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

(2011) Craig H Mermel et al.   GENOME BIOLOGY

Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome

(2010) Johan Staaf et al.   JOURNAL OF CLINICAL ONCOLOGY

Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers

(2009) Lindsay A. Brown et al.   BREAST CANCER RESEARCH AND TREATMENT

PPFIA1andCCND1are frequently coamplified in breast cancer

(2009) Ana-Maria Dancau et al.   GENES CHROMOSOMES & CANCER

Familial Breast Cancers without Mutations in BRCA1 or BRCA2 Have Low Cyclin E and High Cyclin D1 in Contrast to Cancers in BRCA Mutation Carriers

(2008) K. Aaltonen et al.   CLINICAL CANCER RESEARCH

Genetic alterations of CCND1 and EMSY in breast cancers

(2008) T Kirkegaard et al.   HISTOPATHOLOGY

Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases

(2008) Mara Colombo et al.   MODERN PATHOLOGY